Alto Neuroscience ANRO
NYSE ANRO
$25.56 -1.02 (-3.86%)
As of: Sep 30, 2026 · 3:59 PM EDT

Alto Neuroscience (ANRO) Capital Expenditures (2023 - 2026)

Updated

Alto Neuroscience's Capital Expenditures was $556,000 in Q1 2026, compared with $24,000 a year earlier.

Analysis

Alto Neuroscience (ANRO) Capital Expenditures (2023 - 2026) Analysis & Trends

For FY2025, Capital Expenditures at Alto Neuroscience came in at $24,000, down 98.8% from FY2024.

  • In earlier years, Capital Expenditures was $2.08 million in FY2024 (+341.5%) and $470,000 in FY2023.
  • The Q1 2026 figure marks the highest quarterly Capital Expenditures since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Alto Neuroscience 932.10 Mn 932.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 556,000.00
Mar 31, 2025 24,000.00
Dec 31, 2024 506,000.00
Sep 30, 2024 1.01 Mn
Jun 30, 2024 340,000.00
Mar 31, 2024 224,000.00
Dec 31, 2023 352,000.00
Sep 30, 2023 43,000.00
Jun 30, 2023 54,000.00
Mar 31, 2023 21,000.00
API Access

Alto Neuroscience Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ANRO&period=max&api_key=YOUR_API_KEY